CVS Health Co. (NYSE:CVS) Shares Purchased by Aljian Capital Management LLC

Aljian Capital Management LLC grew its holdings in CVS Health Co. (NYSE:CVS) by 21.0% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 13,349 shares of the pharmacy operator’s stock after acquiring an additional 2,319 shares during the quarter. Aljian Capital Management LLC’s holdings in CVS Health were worth $599,000 as of its most recent filing with the SEC.

Other hedge funds have also made changes to their positions in the company. AMF Tjanstepension AB raised its stake in shares of CVS Health by 124.1% during the third quarter. AMF Tjanstepension AB now owns 61,744 shares of the pharmacy operator’s stock worth $3,882,000 after purchasing an additional 34,198 shares during the last quarter. Exchange Traded Concepts LLC lifted its stake in shares of CVS Health by 61.9% in the 3rd quarter. Exchange Traded Concepts LLC now owns 14,853 shares of the pharmacy operator’s stock worth $934,000 after acquiring an additional 5,679 shares during the period. Procyon Advisors LLC acquired a new position in shares of CVS Health during the third quarter worth about $202,000. CX Institutional raised its holdings in CVS Health by 698.0% during the third quarter. CX Institutional now owns 74,609 shares of the pharmacy operator’s stock worth $4,691,000 after purchasing an additional 65,259 shares in the last quarter. Finally, Creative Planning boosted its holdings in CVS Health by 23.5% in the 3rd quarter. Creative Planning now owns 250,891 shares of the pharmacy operator’s stock valued at $15,776,000 after purchasing an additional 47,737 shares in the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have recently commented on CVS shares. Piper Sandler reduced their price target on CVS Health from $72.00 to $64.00 and set an “overweight” rating for the company in a report on Monday, November 25th. Wells Fargo & Company raised CVS Health from an “equal weight” rating to an “overweight” rating and raised their target price for the company from $60.00 to $66.00 in a report on Monday, November 18th. TD Cowen upped their price target on shares of CVS Health from $73.00 to $80.00 and gave the stock a “buy” rating in a research note on Monday, November 25th. Royal Bank of Canada reduced their price objective on shares of CVS Health from $68.00 to $58.00 and set an “outperform” rating for the company in a research note on Friday, November 15th. Finally, Cantor Fitzgerald upgraded shares of CVS Health from a “neutral” rating to an “overweight” rating in a research report on Wednesday. One analyst has rated the stock with a sell rating, four have issued a hold rating and seventeen have issued a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $69.00.

CVS Health Stock Up 15.0 %

CVS opened at $63.23 on Thursday. The business’s fifty day simple moving average is $50.71 and its 200 day simple moving average is $55.94. CVS Health Co. has a 52 week low of $43.56 and a 52 week high of $80.75. The firm has a market cap of $79.57 billion, a P/E ratio of 16.05, a PEG ratio of 0.60 and a beta of 0.61. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 EPS for the quarter, topping analysts’ consensus estimates of $0.89 by $0.30. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. As a group, equities research analysts anticipate that CVS Health Co. will post 5.14 EPS for the current fiscal year.

CVS Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd were issued a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 4.21%. The ex-dividend date was Thursday, January 23rd. CVS Health’s dividend payout ratio (DPR) is 67.51%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.